Patricia Santofimia-Castaño

10PUBLICATIONS
26CO-AUTHORS
Molecular targetsStructural properties of condensed matterNanotoxicology, health and safetyCancer cell biologyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 17, 2025
Synergistic antitumor activity of sorafenib and the NUPR1 inhibitor LZX-2-73 in multiple cancer models.

Xi Liu, Matías Estaras, Emma Cosialls

|Jul 21, 2025
The intrinsically disordered protein NUPR1 binds to phospholipids.

Matías Estaras, Bruno Rizzuti, A Marcela Giudici

|Jun 25, 2025
Self-assembling dendrimer nanodrug formulations for decreased hERG-related toxicity and enhanced therapeutic efficacy.

Xi Liu, Dinesh Dhumal, Patricia Santofimia-Castaño

|Apr 02, 2025
Nuclear Galectin-1 promotes KRAS-dependent activation of pancreatic cancer stellate cells.

Judith Vinaixa, Neus Martínez-Bosch, Joan Gibert

|Feb 15, 2024
Targeting NUPR1-dependent stress granules formation to induce synthetic lethality in KrasG12D-driven tumors.

Patricia Santofimia-Castaño, Nicolas Fraunhoffer, Xi Liu

|Dec 29, 2022
Stroma-targeting strategies in pancreatic cancer: a double-edged sword.

Xi Liu, Juan Iovanna, Patricia Santofimia-Castaño

Pageof 2

Frequent Collaborators

5 joint publications

Juan L Iovanna

4 joint publications

Jose Luis Neira

3 joint publications

Yi Xia

2 joint publications

Bruno Rizzuti